These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 15187105)
1. Expression of human CD1d molecules protects target cells from NK cell-mediated cytolysis. Campos-Martín Y; Gómez del Moral M; Gozalbo-López B; Suela J; Martínez-Naves E J Immunol; 2004 Jun; 172(12):7297-305. PubMed ID: 15187105 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of human NK cell-mediated killing by CD1 molecules. Carbone E; Terrazzano G; Melián A; Zanzi D; Moretta L; Porcelli S; Kärre K; Zappacosta S J Immunol; 2000 Jun; 164(12):6130-7. PubMed ID: 10843662 [TBL] [Abstract][Full Text] [Related]
3. Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice. Saubermann LJ; Beck P; De Jong YP; Pitman RS; Ryan MS; Kim HS; Exley M; Snapper S; Balk SP; Hagen SJ; Kanauchi O; Motoki K; Sakai T; Terhorst C; Koezuka Y; Podolsky DK; Blumberg RS Gastroenterology; 2000 Jul; 119(1):119-28. PubMed ID: 10889161 [TBL] [Abstract][Full Text] [Related]
4. Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice. Hong S; Scherer DC; Singh N; Mendiratta SK; Serizawa I; Koezuka Y; Van Kaer L Immunol Rev; 1999 Jun; 169():31-44. PubMed ID: 10450506 [TBL] [Abstract][Full Text] [Related]
5. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells. Metelitsa LS; Naidenko OV; Kant A; Wu HW; Loza MJ; Perussia B; Kronenberg M; Seeger RC J Immunol; 2001 Sep; 167(6):3114-22. PubMed ID: 11544296 [TBL] [Abstract][Full Text] [Related]
6. Phage display-derived recombinant antibodies with TCR-like specificity against alpha-galactosylceramide and its analogues in complex with human CD1d molecules. Denkberg G; Stronge VS; Zahavi E; Pittoni P; Oren R; Shepherd D; Salio M; McCarthy C; Illarionov PA; van der Merwe A; Besra GS; Dellabona P; Casorati G; Cerundolo V; Reiter Y Eur J Immunol; 2008 Mar; 38(3):829-40. PubMed ID: 18253930 [TBL] [Abstract][Full Text] [Related]
7. Regulation of CD1d expression by murine tumor cells: escape from immunosurveillance or alternate target molecules? Fiedler T; Walter W; Reichert TE; Maeurer MJ Int J Cancer; 2002 Mar; 98(3):389-97. PubMed ID: 11920590 [TBL] [Abstract][Full Text] [Related]
8. BCR targeting of biotin-{alpha}-galactosylceramide leads to enhanced presentation on CD1d and requires transport of BCR to CD1d-containing endocytic compartments. Lang GA; Illarionov PA; Glatman-Freedman A; Besra GS; Lang ML Int Immunol; 2005 Jul; 17(7):899-908. PubMed ID: 15967785 [TBL] [Abstract][Full Text] [Related]
9. Class I-like CD1A-C do not protect target cells from NK-mediated cytolysis. Storkus WJ; Wei M; Cresswell P; Dawson JR Cell Immunol; 1996 Jan; 167(1):154-6. PubMed ID: 8548840 [TBL] [Abstract][Full Text] [Related]
10. Delineation of a CD1d-restricted antigen presentation pathway associated with human and mouse intestinal epithelial cells. van de Wal Y; Corazza N; Allez M; Mayer LF; Iijima H; Ryan M; Cornwall S; Kaiserlian D; Hershberg R; Koezuka Y; Colgan SP; Blumberg RS Gastroenterology; 2003 May; 124(5):1420-31. PubMed ID: 12730881 [TBL] [Abstract][Full Text] [Related]
11. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. Benlagha K; Weiss A; Beavis A; Teyton L; Bendelac A J Exp Med; 2000 Jun; 191(11):1895-903. PubMed ID: 10839805 [TBL] [Abstract][Full Text] [Related]
12. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR. Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390 [TBL] [Abstract][Full Text] [Related]
13. Regulation of immune responses by CD1d-restricted natural killer T cells. Van Kaer L Immunol Res; 2004; 30(2):139-53. PubMed ID: 15477656 [TBL] [Abstract][Full Text] [Related]
14. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice. Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262 [TBL] [Abstract][Full Text] [Related]
15. The murine nonclassical class I major histocompatibility complex-like CD1.1 molecule protects target cells from lymphokine-activated killer cell cytolysis. Chang CS; Brossay L; Kronenberg M; Kane KP J Exp Med; 1999 Feb; 189(3):483-91. PubMed ID: 9927510 [TBL] [Abstract][Full Text] [Related]
16. Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes. Burdin N; Brossay L; Koezuka Y; Smiley ST; Grusby MJ; Gui M; Taniguchi M; Hayakawa K; Kronenberg M J Immunol; 1998 Oct; 161(7):3271-81. PubMed ID: 9759842 [TBL] [Abstract][Full Text] [Related]
17. CD1d1 displayed on cell size beads identifies and enriches an NK cell population negatively regulated by CD1d1. Huang MM; Borszcz P; Sidobre S; Kronenberg M; Kane KP J Immunol; 2004 May; 172(9):5304-12. PubMed ID: 15100269 [TBL] [Abstract][Full Text] [Related]
18. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen. Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017 [TBL] [Abstract][Full Text] [Related]
19. A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas. Crowe NY; Smyth MJ; Godfrey DI J Exp Med; 2002 Jul; 196(1):119-27. PubMed ID: 12093876 [TBL] [Abstract][Full Text] [Related]
20. Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. Singh N; Hong S; Scherer DC; Serizawa I; Burdin N; Kronenberg M; Koezuka Y; Van Kaer L J Immunol; 1999 Sep; 163(5):2373-7. PubMed ID: 10452969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]